Drug Trial Radar · NCT00295854
Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Last checked: Nov 19, 2026Latest source record: Jan 19, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
296
Actual
Start
May 2005
Primary completion
Oct 2006
Study completion Oct 2006
Sponsor
- Lead sponsor
- MediciNovaIndustry
- Sponsor type
- Industry
- First posted
- Feb 24, 2006
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of 8 weeks of treatment with MN-001 at 500 mg bid, 500 mg once daily vs. placebo in patients with Interstitial Cystitis.
Conditions
- Interstitial Cystitis
Interventions
MN-001 BIDDrug
Eligible patients received 500 mg MN-001 bid
MN-001Drug
Eligible patients received 500 mg MN-001 once daily (qd)
PlaceboDrug
Eligible patients received placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number Subjects at Least "Moderately Improved" for Each Treatment Group in Patient Reported Global Response Assessment (GRA)Time frame: 8 weeks
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
MediciNova Investigational Site
Birmingham, Alabama
Citrus Valley Urological Medical Group
Glendora, California
Atlantic Urological Medical Group
Long Beach, California
Mendez Transplant and Urological Medical Group
San Diego, California
Boulder Medical Center, P.C.
Boulder, Colorado
Western Urologic Research Center
Wheat Ridge, Colorado
Segal Institute for Clinical Research
Aventura, Florida
Visions Clinical Research
Boynton Beach, Florida
West Florida Urology
Palm Harbor, Florida
Adult and Pediatric Urology
Plantation, Florida
Georgis Patsias, MD., PA
Wellington, Florida
Shepherd Center, Inc.
Atlanta, Georgia
Center For Advanced Pelvic Surgery
Centralia, Illinois
Evanston Continence Center
Evanston, Illinois
Regional Urology, LLC
Shreveport, Louisiana
William Beaumont Hospital
Royal Oak, Michigan
Sheldon J. Freedman, MD, LTD
Las Vegas, Nevada
Associated Urologic Specialists, P.A.
Marlton, New Jersey
Upstate Urology
Albany, New York
Lyndhurst Gynecology Associates
Winston-Salem, North Carolina
Tristate Urologic Services PSC., Inc.
Cincinnati, Ohio
Midwest Regional Center For Chronic Pelvic Pain and Bladder Control
Lima, Ohio
Williamette Women's Healthcare P.C.
Tualatin, Oregon
The Urology Group
Greer, South Carolina
Medical Arts Clinic
Corsicana, Texas
Gant Foundation
Fort Worth, Texas
Brian Heaton, MD
Ogden, Utah
Integrity Medical Research, LLC
Mountlake Terrace, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.